Inactivated whole-virus vaccines against porcine parvovirus (PPV) can prevent disease but not infection and virus shedding after heterologous virus challenge. Here, we showed that the same is true for a homologous challenge. Pregnant sows were vaccinated with an experimental inactivated vaccine based on PPV strain 27a. They were challenged on day 40 of gestation with the virulent porcine parvovirus PPV-27a from which the vaccine was prepared (homologous challenge). On day 90 of gestation, the fetuses from vaccinated sows were protected against disease, while the fetuses of the non-vaccinated sows (control group) exhibited signs of parvovirus disease. All gilts, whether vaccinated or not vaccinated, showed a boost of PPVspecific antibodies indicative of virus infection and replication. Low DNA copy numbers, but not infectious virus, could be demonstrated in nasal or rectal swabs of immunized sows, but high copy numbers of challenge virus DNA as well as infectious virus could both be demonstrated in non-vaccinated sows.
Porcine parvovirus (PPV) is a ssDNA virus belonging to the family Parvoviridae. Infection with PPV can lead to stillbirth, mummification of the fetus, embryonic death and infertility (termed SMEDI syndrome) and delayed return of oestrus (Mengeling et al., 2000) . The severity of these reproductive failures depends on the pathogenicity of the virus strain and on the stage of gestation (Nielsen et al., 1991) . An infection that takes place before day 30 of gestation leads to fetal death and resorption, while infection between days 30 and 65 leads to fetal death and subsequent mummification. If the fetuses are infected after day 70 of gestation, they usually develop antibodies against PPV and eliminate the virus (Zeeuw et al., 2007; Truyen & Streck, 2012) . In recent years, studies have shown that PPV is much more diverse than previously thought (Zimmermann et al. 2006; Streck et al., 2011) . Several PPV strains of different virulence are known. The genetic basis of this virulence has not yet been defined, but the structural protein appears to play a major role, as a genomic comparison between the non-pathogenic strain NADL2 and the virulent strain Kresse revealed that the non-coding regions of the genome are nearly identical (Bergeron et al., 1996) .
Based on phylogenetic analyses of the VP1/VP2 protein genes, PPV can be defined into at least seven clusters (Zimmermann et al., 2006; Streck et al., 2011 Streck et al., , 2013a . Recently, a population dynamic analysis showed that, despite the high evolutionary rate, only a few PPV strains (similar to strain 27a) have been predominant in Europe in recent years (Streck et al., 2013b) . For this reason, it is hypothesized that new PPV strains may interfere with the efficacy of the currently used vaccines (Truyen & Streck, 2012) .
The currently used whole-virus inactivated vaccines are based mainly on strain NADL2 and similar strains, isolated some 40 years ago (Józ´wik et al., 2009) . A previous study has shown that these vaccines can protect against disease but do not prevent infection and virus shedding after challenge infection with a virus from an antigenically heterologous strain (Józ´wik et al., 2009) . Therefore, the aim of this study was to examine whether immunization with a homologous virus could protect against infection with the homologous challenge virus, protect against disease, and minimize or even prevent virus shedding of the challenge virus from vaccinated sows. An experimental vaccine based on the highly virulent and predominant strain 27a (PPV-27a) was manufactured and used to immunize gravid sows, and its efficacy was evaluated after challenge infection with the homologous parental virus.
For vaccination, an experimental vaccine based on PPV-27a was used. The vaccine was prepared by IDT Biologika GmbH based on inactivated whole virus (1024 haemagglutination units ml
À1
, corresponding to a virus titre of about 10 5 TCID 50 ml À1 before inactivation), preserved with thiomersal and adjuvanted with Carbopol. For the experimental challenge infection, PPV-27a was used (homologous virus challenge). The PPV-27a seed had an infectivity titre (TCID 50 ) of 10 6 ml
. Sterile pyrogen-free saline solution was applied as a placebo. A total of 5 Â 10 6 TCID 50 PPV27a per animal was used in the challenge experiment.
The animal experiment was approved by the 'Landesdirektion Sachsen' (AZ: 24-9168.21/4/28-2012/98739). Twenty mixed-breed 'German Landrasse/Pietrain', primiparous gilts aged 7 months were tested negative for specific antibodies against PPV by haemagglutination inhibition (HI) test before the experiment started. The animals were divided into two groups and housed in the animal facility of the Veterinary Faculty of the University of Leipzig. One group of 12 gilts received the vaccine (group A) and a control group represented by eight gilts received the placebo (group B). One sow of each group had to be excluded during the experiment because of trauma not related to the experiment.
The gilts were synchronized using the common protocols of Regu-Mate and Ovogest and inseminated as described previously (Zeeuw et al., 2007) .
For immunization, 2 ml vaccine or PBS (placebo) was applied intramuscularly. The first shot was given on day 35 before insemination and the booster was given 21 days later. All pregnant sows from both groups were inoculated on day 40 of gestation with 5 ml PPV-27 suspension (2 ml was applied in each nostril and 1 ml intramuscularly in the neck).
The health status of the gilts was monitored daily, and clinical signs, overall condition, food and water intake and external appearance of the genital organs were recorded. Throughout the experiment, blood samples were taken at regular intervals and tested for antibodies by HI test and serum neutralization test (SNT). Blood was collected on the days of the first (day À75) and second (day À54) vaccination, on day À37, on the day of infection (day 0), and on days 7, 14, 21 and 49 after infection. Rectal and nasal swab samples were taken at the same time points and nine times over a period of 3 weeks after infection. They were analysed by quantitative real-time PCR (qPCR) and virus isolation in tissue culture for possible virus shedding.
At day 90 of gestation (49 days after infection), all gilts were euthanized using pentobarbital and the fetuses were delivered. Their size, weight, position in utero and morphology were recorded, and samples from umbilical blood, lungs and kidneys were collected from each fetus and analysed.
All serum samples were heat inactivated at 56 C for 30 min, and tested by HI test and serum SNT, as described previously (Zeeuw et al., 2007) .
The DNA of organ tissues and nasal swabs was purified with a QIAamp DNA Mini kit (Qiagen) and from rectal swabs using a QIAamp DNA Stool kit (Qiagen) according to the manufacturer's instructions. Subsequently, PPV DNA was quantified by real-time qPCR as described by Streck et al. (2015) . The sensitivity of the assay was about 20 copies PPV DNA per reaction.
For virus isolation, swabs were eluted with 2 ml PBS and chloroform. Twenty-five microlitres of the supernatant was added per well to PK15 cells in a 12-well microtitre plate. The plates were observed daily for the appearance of a cytopathic effect.
To confirm the cytopathic effect of the serum neutralization and the virus isolation, the corresponding plates were examined further by immunofluorescence after fixation with acetone and using a polyclonal pig serum, as described previously (Zeeuw et al., 2007) .
Beside the mummified fetuses in the sows of the control group, the animals did not show any clinical signs attributable to infection or vaccination. The fetuses from sows in the control group showed different degrees of mummification. The percentage of mummified fetuses in group B (non-vaccinated sows) was 50.62 %, which was over 10 times higher compared with 4.1 % in group A (vaccinated sows) ( Table 1 ). The crown-rump length of the few mummified fetuses from a sow of group A indicated that they died before PPV infection, and were therefore most likely not due to a vaccine failure. Besides this, no differences in length or weight were observed in the non-mummified fetuses of both groups. A higher mortality in the unvaccinated sows was clearly evident (Table 1) .
After vaccination, all 11 sows who received the vaccine seroconverted within 5 weeks, with an antibody titre of up to 640, as determined by HI (Table 2) . After challenge infection, in all sows -both vaccinated and unvaccinated -the titres rose to 1280 or higher. The post-infection titres of the non-vaccinated gilts were slightly higher than those of the vaccinated gilts. These results were confirmed by SNT (data not shown). The drop of one to two dilution steps probably reflects the physiological waning of the humoral immune response raised by an inactivated vaccine. As all vaccinated sows developed a strong antibody response upon challenge infection, it was obvious that a replicating virus stimulated the immune system more efficiently. The significance of the differences in the antibody titres on days 14, 21 and 49 postinfection (p.i.) between the vaccinated and non-vaccinated sows was calculated using the one-tailed Mann-Whitney U test. For all three time points, the differences were found to be significant (P=0.0082, P=0.02559 and P= 0.0004, respectively). It was hypothesized that the vaccine-induced antibody titres interfered with the replication of the challenge virus and hindered to some extent the induction of antibodies. The drop in antibody titres of the vaccinated sows from day À37 to the day of challenge infection was surprising.
In both groups, fetuses with positive antibody titres in the umbilical blood were detected. Curiously, low antibody titres were observed in vaccinated animals, even in qPCR-negative fetuses. As maternal antibody cannot cross the placental barrier (Mengeling et al., 2000) , this phenomenon most likely represents a euthanization artefact, resulting from contamination with maternal blood, rather than active virus replication in immunocompetent fetuses.
In contrast, in group A (vaccinated sows), only very low antibody titres of up to 10 were observed in 13/122 fetuses, whereas antibody titres observed in 30/81 fetuses from the non-vaccinated sows (group B) ranged from 10 up to 41 600 (Table 1) . Viral DNA could not be detected by qPCR in the lung or kidney of any of the 122 fetuses (0 %) from vaccinated sows (Table 3) . However, in 55/81 (67.9 %) fetuses from nonvaccinated sows, virus could readily be detected in the various tissues. The mean number of viral genomic copies in these tissues was 7.99 Â 10 9 µl
. While only 41/51 PPVinfected fetuses were mummified, PPV was demonstrated in 14 apparently healthy fetuses, which did not show any signs of disease.
After infection, virus was shed from animals of both groups, as determined by qPCR. High shedding of virus could be detected until day 9, but some sows shed virus for as many as 49 days p.i. In the non-vaccinated sows, virus DNA could be detected in 29.9 % of all swabs, whereas in the vaccinated sows only 4.1 % were positive. The copy number of viral DNA differed between the groups. Whereas in non-vaccinated sows, viral genomic copies up to 7.79 Â 10 4 µl À1 (mean of 2.87 Â 10 3 µl À1 ) were detected, only a maximum number of genomic copies up to 2.831 Â 10 3 µl À1 (mean of 3.04 Â 10 2 µl À1 ) was seen in vaccinated sows (Table 3) . Applying the two-tailed Mann-Whitney U test, the combined values for nasal and faecal viral DNA shedding was highly significant between the two groups (P<0.0001).
The weakly positive samples at day 2 and 4 p.i. were most likely residual inoculum. Considering the sensitivity of the PCR at 20 copies per reaction, only very small amounts of DNA were detected. Contamination of the animals or the swabs taken from these animals cannot be fully excluded in an animal experiment with pigs of more than 100 kg body mass and housed in a group. In Table 1 . Number of mummified and non-affected fetuses in the two groups and results of virological and serological analyses of tissues and umbilical blood contrast, contamination in the laboratory can almost be excluded as all appropriate negative controls for purification of the DNA and for the real-time PCR were always negative. As a negative control, water was used instead of the sample during DNA purification and subsequent PCR, and a non-template control for the real-time PCR was always included.
All qPCR-positive tested swabs were investigated further by cell culture for the presence of infectious virus. After inoculation, a cytopathic effect could be observed in the first passage after 7 days in only four of these positives samples, all from three non-vaccinated sows (group B, sow numbers 378, 380 and 381).
The results of this study are very similar to those of a previous study (Józ´wik et al., 2009) where an inactivated wholevirus vaccine was tested against a challenge infection with an antigenically heterologous virus. It was observed in that study that vaccination prevented reproductive disorders but not infection and subsequent shedding of the heterologous challenge virus. The data at that time were interpreted as an incomplete protection after heterologous challenge virus infection.
Here, we were able to examine the protection after virus challenge with an antigenically homologous virus, expecting protection against disease but also a complete prevention of virus shedding after virus challenge. The results showed that the experimenteal PPV-27a vaccine prevented fetal death after homologous virus challenge with PPV-27a. However, as with the heterologous challenge, all sows showed a substantial increase in antibody titres after infection, suggesting that neither homologous nor heterologous vaccines can prevent virus infection. Furthermore, shedding of genomic DNA could be detected in both vaccinated and non-vaccinated sows after infection, although the number of sows that shed viral DNA and the magnitude differed markedly between the groups (Table 3) . Infectious virus was only recovered from three non-vaccinated sows and not from any vaccinated sow. The sows that shed infectious virus also shed high copy numbers of viral DNA.
It is not clear whether the shedding of very low copy numbers of viral DNA is of epidemiological importance, as infectious virus could not be recovered from any vaccinated sow. Based on the challenge experiments described here and those reported previously (Józ´wik et al., 2009) , an inactivated vaccine does not induce a sterile immunity against a challenge infection, even against a homologous challenge virus, and may not completely prevent virus shedding. <10  <10  <10  160  10 400  5200  2560  379  <10  <10  <10  <10  80  10 400  5200  5200  380  <10  <10  <10  <10  320  10 400  5200  5200  381  <10  <10  <10  <10  80  10 400  5200  5200  382  <10  <10  <10  <10  640  20 800  5200  10 400  383  <10  <10  <10  <10  80  2560  1280  2560  384  <10  <10  <10  <10  <10  5200  2560  5200 Table 3 . Shedding of PPV from the day of challenge infection until day 49 p.i. 
